 Pathogenesis recent therapeutic approaches graft-versus-host disease Effective prophylaxis acute GVHD improved patient survival severe infections first months transplantation incidence chronic GVHD quality hematopoietic engraftment incidence leukemic relapse graft-versus-leukemia effect None current approaches prevention GVHD expectations immunosuppressive therapy ideal technique cell depletion effective incidence GVHD programs successful host immune malignant cells doubtful systemic chemotherapy total body irradiation Innovative approaches use monoclonal antibodies short-lived radioactive isotopes short linear energy transfer promise toxic efficient programs eradication malignant disease problem graft failure conceivable possible leukemic cells chemoradiotherapy form graft-versus-leukemia effect essential future possible lymphocytes graft-versus-leukemia effect GVHD attempts therapy meantime immunosuppressive drugs GVHD survival statistics